- Home
- LPTH vs ADAG Comparison
LPTH vs ADAG Comparison
Compare LPTH & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- ADAG
- Stock Information
- Founded
- LPTH 1985
- ADAG 2011
- Country
- LPTH United States
- ADAG China
- Employees
- LPTH N/A
- ADAG N/A
- Industry
- LPTH Semiconductors
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- ADAG Health Care
- Exchange
- LPTH Nasdaq
- ADAG Nasdaq
- Market Cap
- LPTH 81.1M
- ADAG 81.9M
- IPO Year
- LPTH 1996
- ADAG 2021
- Fundamental
- Price
- LPTH $2.19
- ADAG $1.42
- Analyst Decision
- LPTH Strong Buy
- ADAG Strong Buy
- Analyst Count
- LPTH 3
- ADAG 1
- Target Price
- LPTH $4.67
- ADAG $8.00
- AVG Volume (30 Days)
- LPTH 111.5K
- ADAG 29.9K
- Earning Date
- LPTH 05-08-2025
- ADAG 03-24-2025
- Dividend Yield
- LPTH N/A
- ADAG N/A
- EPS Growth
- LPTH N/A
- ADAG N/A
- EPS
- LPTH N/A
- ADAG N/A
- Revenue
- LPTH $32,158,517.00
- ADAG $103,204.00
- Revenue This Year
- LPTH $16.90
- ADAG $6,488.89
- Revenue Next Year
- LPTH $52.77
- ADAG $57.50
- P/E Ratio
- LPTH N/A
- ADAG N/A
- Revenue Growth
- LPTH N/A
- ADAG N/A
- 52 Week Low
- LPTH $1.04
- ADAG $1.33
- 52 Week High
- LPTH $4.42
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- LPTH 57.00
- ADAG 39.32
- Support Level
- LPTH $1.90
- ADAG $1.36
- Resistance Level
- LPTH $2.13
- ADAG $1.92
- Average True Range (ATR)
- LPTH 0.17
- ADAG 0.13
- MACD
- LPTH 0.05
- ADAG -0.00
- Stochastic Oscillator
- LPTH 93.55
- ADAG 13.79
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.